Results 271 to 280 of about 141,477 (341)

Sex related differences in efficacy and safety of antithrombotic therapy in patients with coronary artery disease: systematic review and meta-analysis.

BMJ
Piccolo R, Laino A, Vitale AP, Franzone A, Esposito G.   +4 more
europepmc   +1 more source

Assessing the efficacy and safety of low dose clopidogrel in Chinese ACS patients undergoing PCI: A retrospective study. [PDF]

Medicine (Baltimore)
Cheng B, Kong X, Chen J, He Q, Zhou M, Deng A.   +5 more
europepmc   +1 more source

Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: A new drug-drug interaction

, 2003
Wei C. Lau, Lucy Waskell, Paul B. Watkins, Charlene J. Neer, Kevin Horowitz, Amy S. Hopp, Alan R. Tai, David G.M. Carville, Kirk E. Guyer, Eric Bates   +9 more
openalex   +2 more sources

Genetic Polymorphisms and Clopidogrel Efficacy for Acute Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis

Circulation, 2017
Yuesong Pan, Weiqi Chen, Yun Xu, X. Yi, Yan Han, Qingwu Yang, Xin Li, Lian Huang, S. Johnston, Xingquan Zhao, Liping Liu, Qi Zhang, Guangyao Wang, Yongjun Wang, Yilong Wang   +14 more
semanticscholar   +1 more source

The efficacy and safety of antithrombotic therapy in patients undergoing TAVI: a network meta-analysis. [PDF]

BMC Cardiovasc Disord
Han J, Liu K, Li Y, Han D, Liang P, Zhao N, Hu S, Yan X.   +7 more
europepmc   +1 more source

Genetic and clinical determinants of MACE and haemorrhage in antiplatelet therapy: insights from pharmacogenomic analysis. [PDF]

Front Cardiovasc Med
Wang Y, Yuan S, Li M, Feng W, Li J, Chen W, Berdi A, Kou Y, Yuan Y, Zhao J.   +9 more
europepmc   +1 more source

Ticagrelor-Induced Dermatological Hypersensitivity Reaction. [PDF]

Cureus
Lunge S, Doshi SR, Sardesai VR.
europepmc   +1 more source

Advances in emerging therapies 2006 [PDF]

, 2007
Dawson, J., Lees, K.R.
core   +2 more sources

Rationale and design of randomized non-inferiority clinical trial to compare the safety and efficacy of ticagrelor monotherapy with dual antiplatelet therapy in chronic coronary syndrome patients post percutaneous coronary intervention (TICALONE-TAHA10 Protocol). [PDF]

PLoS One
Mirhosseini SA, Akbari M, Aldavood D, Zarifkar H, Attar A, Kojuri J.   +5 more
europepmc   +1 more source

PCV63 COST-EFFECTIVENESS ANALYSIS OF CLOPIDOGREL IN ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION IN THE NETHERLANDS

, 2003
BA Van Hout, MJD Tangelder, P Bervoets, S Gabriel   +3 more
openalex   +1 more source